Completed PHASE2 INTERVENTIONAL 2-arm NCT05888597

Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease (Ment-COPD)

Effect of L-menthol on Breathlessness and Exercise Capacity in Chronic Obstructive Pulmonary Disease: a Randomized

Sponsor: Lund University

Conditions Chronic Obstructive Pulmonary Disease (COPD)

Updated 6 times since 2023 Last updated: Dec 2, 2025 Started: May 24, 2023 Primary completion: Apr 30, 2025 Completion: Apr 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05888597, this PHASE2 trial focuses on Chronic Obstructive Pulmonary Disease (COPD) and remains completed. Sponsored by Lund University, it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2

Status: Recruiting → Completed
Sep 2024 — Jan 2026 [monthly]

Recruiting PHASE2
Aug 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jul 2024 — Aug 2024 [monthly]

Recruiting PHASE2
Dec 2023 — Jul 2024 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jul 2023 — Dec 2023 [monthly]

Not Yet Recruiting PHASE2

First recorded

May 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lund University
Region Skane

Data source: Region Skane

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lund, Sweden